Search research articles
Contact Us
Filters
Showing results (191-200 of 201) with videos related to
Page
of 21
Sort By:
Diabetologia
|
June 11, 2014
AMPK phosphorylation of ACC2 is required for skeletal muscle fatty acid oxidation and insulin sensitivity in mice
Hayley M O'Neill, James S Lally, Sandra Galic, et al.
Journal of Medicinal Chemistry
|
August 20, 2015
Discovery and Optimization of 4-(8-(3-Fluorophenyl)-1,7-naphthyridin-6-yl)transcyclohexanecarboxylic Acid, an Improved PDE4 Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease (COPD)
Neil J Press, Roger J Taylor, Joseph D Fullerton, et al.
Nature Medicine
|
December 9, 2014
Inhibiting peripheral serotonin synthesis reduces obesity and metabolic dysfunction by promoting brown adipose tissue thermogenesis
Justin D Crane, Rengasamy Palanivel, Emilio P Mottillo, et al.
Journal of Medicinal Chemistry
|
August 15, 2012
Solubility-driven optimization of phosphodiesterase-4 inhibitors leading to a clinical candidate
Neil J Press, Roger J Taylor, Joseph D Fullerton, et al.
Plos Pathogens
|
September 25, 2023
Choline metabolism underpins macrophage IL-4 polarization and RELMα up-regulation in helminth infection
Peyman Ghorbani, Sang Yong Kim, Tyler K T Smith, et al.
Atherosclerosis
|
June 16, 2024
AMPK-mediated regulation of endogenous cholesterol synthesis does not affect atherosclerosis in a murine Pcsk9-AAV model
Tyler K T Smith, Peyman Ghorbani, Nicholas D LeBlond, et al.
JCI Insight
|
December 6, 2022
Hepatocyte-derived DPP4 regulates portal GLP-1 bioactivity, modulates glucose production, and when absent influences NAFLD progression
Natasha A Trzaskalski, Branka Vulesevic, My-Anh Nguyen, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 6, 2007
Potent and selective xanthine-based inhibitors of phosphodiesterase 5
Nichola J Arnold, Ruth Arnold, David Beer, et al.
EMBO Molecular Medicine
|
February 11, 2015
Defective NOD2 peptidoglycan sensing promotes diet-induced inflammation, dysbiosis, and insulin resistance
Emmanuel Denou, Karine Lolmède, Lucile Garidou, et al.
Molecular Psychiatry
|
February 19, 2026
Pharmacogenomics of antiepileptic drug mood stabilizer treatment response in bipolar disorder: A MoStGen Consortium study
Ada Man-Choi Ho, Brandon J Coombes, Anthony Batzler, et al.
Page
of 21
Search research articles
Search
Showing results (191-200 of 201) with videos related to
Sort By:
Page
of 21
Diabetologia
|
June 11, 2014
AMPK phosphorylation of ACC2 is required for skeletal muscle fatty acid oxidation and insulin sensitivity in mice
Hayley M O'Neill, James S Lally, Sandra Galic, et al.
Journal of Medicinal Chemistry
|
August 20, 2015
Discovery and Optimization of 4-(8-(3-Fluorophenyl)-1,7-naphthyridin-6-yl)transcyclohexanecarboxylic Acid, an Improved PDE4 Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease (COPD)
Neil J Press, Roger J Taylor, Joseph D Fullerton, et al.
Nature Medicine
|
December 9, 2014
Inhibiting peripheral serotonin synthesis reduces obesity and metabolic dysfunction by promoting brown adipose tissue thermogenesis
Justin D Crane, Rengasamy Palanivel, Emilio P Mottillo, et al.
Journal of Medicinal Chemistry
|
August 15, 2012
Solubility-driven optimization of phosphodiesterase-4 inhibitors leading to a clinical candidate
Neil J Press, Roger J Taylor, Joseph D Fullerton, et al.
Plos Pathogens
|
September 25, 2023
Choline metabolism underpins macrophage IL-4 polarization and RELMα up-regulation in helminth infection
Peyman Ghorbani, Sang Yong Kim, Tyler K T Smith, et al.
Atherosclerosis
|
June 16, 2024
AMPK-mediated regulation of endogenous cholesterol synthesis does not affect atherosclerosis in a murine Pcsk9-AAV model
Tyler K T Smith, Peyman Ghorbani, Nicholas D LeBlond, et al.
JCI Insight
|
December 6, 2022
Hepatocyte-derived DPP4 regulates portal GLP-1 bioactivity, modulates glucose production, and when absent influences NAFLD progression
Natasha A Trzaskalski, Branka Vulesevic, My-Anh Nguyen, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 6, 2007
Potent and selective xanthine-based inhibitors of phosphodiesterase 5
Nichola J Arnold, Ruth Arnold, David Beer, et al.
EMBO Molecular Medicine
|
February 11, 2015
Defective NOD2 peptidoglycan sensing promotes diet-induced inflammation, dysbiosis, and insulin resistance
Emmanuel Denou, Karine Lolmède, Lucile Garidou, et al.
Molecular Psychiatry
|
February 19, 2026
Pharmacogenomics of antiepileptic drug mood stabilizer treatment response in bipolar disorder: A MoStGen Consortium study
Ada Man-Choi Ho, Brandon J Coombes, Anthony Batzler, et al.
Page
of 21